[HTML][HTML] Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
JX He, M Wang, XJ Huan, CH Chen, SS Song… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The approval of poly (ADP-ribose) polymerase (PARP) inhibitor AZD2281 in 2014 marked
the successful establishment of the therapeutic strategy targeting homologous …
the successful establishment of the therapeutic strategy targeting homologous …
[PDF][PDF] Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
YQW Song, XM Liao, C Tan, Q He, LJ Tong, YT Wang… - pdfs.semanticscholar.org
The approval of poly (ADP-ribose) polymerase (PARP) inhibitor AZD2281 in 2014 marked
the successful establishment of the therapeutic strategy targeting homologous …
the successful establishment of the therapeutic strategy targeting homologous …
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.
JX He, M Wang, XJ Huan, CH Chen, SS Song… - Oncotarget, 2017 - europepmc.org
The approval of poly (ADP-ribose) polymerase (PARP) inhibitor AZD2281 in 2014 marked
the successful establishment of the therapeutic strategy targeting homologous …
the successful establishment of the therapeutic strategy targeting homologous …
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
JX He, M Wang, XJ Huan, CH Chen, SS Song… - …, 2017 - pubmed.ncbi.nlm.nih.gov
The approval of poly (ADP-ribose) polymerase (PARP) inhibitor AZD2281 in 2014 marked
the successful establishment of the therapeutic strategy targeting homologous …
the successful establishment of the therapeutic strategy targeting homologous …
[HTML][HTML] Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
JX He, M Wang, XJ Huan, CH Chen, SS Song… - Oncotarget, 2016 - oncotarget.com
Abstract Jin-Xue He 1,*, Meng Wang 2,*, Xia-Juan Huan 1, Chuan-Huizi Chen 1, Shan-Shan
Song 1, Ying-Qing Wang 1, Xue-Mei Liao 1, Cun Tan 2, Qian He 2, Lin-Jiang Tong 1, Yu …
Song 1, Ying-Qing Wang 1, Xue-Mei Liao 1, Cun Tan 2, Qian He 2, Lin-Jiang Tong 1, Yu …
[PDF][PDF] Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
YQW Song, XM Liao, C Tan, Q He, LJ Tong, YT Wang… - researchgate.net
The approval of poly (ADP-ribose) polymerase (PARP) inhibitor AZD2281 in 2014 marked
the successful establishment of the therapeutic strategy targeting homologous …
the successful establishment of the therapeutic strategy targeting homologous …
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution
JX He, M Wang, XJ Huan, CH Chen, SS Song… - Oncotarget, 2016 - oncotarget.com
Abstract Jin-Xue He 1,*, Meng Wang 2,*, Xia-Juan Huan 1, Chuan-Huizi Chen 1, Shan-Shan
Song 1, Ying-Qing Wang 1, Xue-Mei Liao 1, Cun Tan 2, Qian He 2, Lin-Jiang Tong 1, Yu …
Song 1, Ying-Qing Wang 1, Xue-Mei Liao 1, Cun Tan 2, Qian He 2, Lin-Jiang Tong 1, Yu …